# Nasser H. Hanna

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nasser-h-hanna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,654 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 59 |
| i10-index | 161 |
| Last Known Institution | Indiana University School of Medicine |
| OpenAlex ID | https://openalex.org/A5074428655 |
| ORCID iD | https://orcid.org/0000-0002-7046-6426 |
| Works | 468 |

## Researcher papers

- [Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy](https://scholariq.org/papers/randomized-phase-iii-trial-of-pemetrexed-versus-docetaxel-in-patients-with-non/)
- [A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)](https://scholariq.org/papers/a-randomized-phase-ii-study-of-the-mek1-mek2-inhibitor-trametinib-gsk1120212/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments-2/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Indiana University School of Medicine](https://scholariq.org/institutions/indiana-university-school-of-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.